Active	Status	Sponsor type	Region	Phase	Filter
16 Active 1 Inactive 17 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

16 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Young, Jennifer
NCT05198674: SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN	Recruiting	N/A	1400	Europe, US, RoW	Renal Denervation (Symplicity Spyral™), Renal Angiography, Renal Denervation	Medtronic Vascular	Hypertension, Vascular Diseases, Cardiovascular Diseases, Chronic Kidney Diseases, Diabetes Mellitus	11/26	11/29
NCT03643224: DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation	Active, not recruiting	N/A	376	Europe, Canada, US, RoW	Radiofrequency Ablation	Medtronic Cardiac Rhythm and Heart Failure	Persistent Atrial Fibrillation, Atrial Fibrillation	10/24	12/24
ADVANTAGE AF, NCT05443594: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation	Active, not recruiting	N/A	669	Europe, Canada, US	Phase 1: FARAPULSE Ablation System, Phase 2: FARAPULSE Ablation System	Boston Scientific Corporation	Persistent Atrial Fibrillation	03/25	03/25
NCT05537753: Encore PFO Closure Device - The PerFOrm Trial	Recruiting	N/A	500	US	Encore PFO closure device, FDA-approved PFO closure device	Encore Medical Inc., Bright Research Partners, Yale Cardiovascular Research Group	Patent Foramen Ovale, Cryptogenic Stroke	04/25	10/29
IONA-MM, NCT04458831: A Prospective, Non-interventional, Multinational, Observational Study With Isatuximab in Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM)	Recruiting	N/A	1200	Europe, Japan, US, RoW	isatuximab SAR650984, Sarclisa, Pomalidomide, Pomalyst, Dexamethasone, Carfilzomib	Sanofi	Plasma Cell Myeloma	02/26	02/26
Campbell, Dwayne
SyncAV, NCT04100148: Post-Market Trial	Active, not recruiting	N/A	1686	Europe, Canada, Japan, US, RoW	SyncAV programmed ON, Fixed AV delay	Abbott Medical Devices	Congestive Heart Failure	06/25	12/25
NCT04496518: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)	Recruiting	N/A	2200	Europe, US	Intrinsic Antitachycardia Pacing (iATP) Therapy	Medtronic	Ventricular Tachycardia	01/25	01/27
NCT04489225: Personalized Therapy Study - HFRS (TriageHF) Post Approval Study	Recruiting	N/A	2200	Europe, US	Observational	Medtronic	Heart Failure	01/25	01/27
ASQ, NCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study	Active, not recruiting	N/A	1008	Europe, US	Quadripolar LV Lead, Medtronic CRT-P, Medtronic CRT-D	Medtronic	Heart Failure	01/27	04/27
NCT06048731: Enlighten Study: The EV-ICD Post Approval Registry	Recruiting	N/A	1000	Europe, Canada, US, RoW	Defibrillation using EV-ICD	Medtronic	Ventricular Arrhythmia, Tachycardia	05/30	10/37
Hounshell, Troy
NCT03811795: Cryoballoon vs. Rhythmia Guided Ablation for Recurrent AFib	Recruiting	N/A	50	US	ECG monitoring with a Kardia Mobile monitor	Valley Health System	Atrial Fibrillation	11/22	11/23
NCT05809596: HEAL-LAA Clinical Trial	Recruiting	N/A	1000	US	WATCHMAN FLX Pro LAAC Device, Left Atrial Appendage Closure	Boston Scientific Corporation	Atrial Fibrillation, Bleeding, Stroke	08/24	06/25
ADVANTAGE AF, NCT05443594: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects With Persistent Atrial Fibrillation	Active, not recruiting	N/A	669	Europe, Canada, US	Phase 1: FARAPULSE Ablation System, Phase 2: FARAPULSE Ablation System	Boston Scientific Corporation	Persistent Atrial Fibrillation	03/25	03/25
Meyers, Jason
NCT03505801: Confirm Rx Insertable Cardiac Monitor SMART Registry	Active, not recruiting	N/A	1826	Europe, Canada, Japan, US, RoW	Confirm Rx ICM insertion procedure	Abbott Medical Devices	Cardiac Arrhythmias, Symptoms and Signs, Atrial Fibrillation	09/19	03/26
AVANT GUARD, NCT06096337: Pulsed Field Ablation (PFA) Versus Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation	Recruiting	N/A	387	Europe, Canada, US, RoW	FARAPULSE™ Pulsed Field Ablation (PFA) System, Anti-Arrhythmic Drug (AAD): Flecainide, Sotalol, Propafenone, and Dofetilide	Boston Scientific Corporation	Persistent Atrial Fibrillation	12/25	12/27
NCT03643224: DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation	Active, not recruiting	N/A	376	Europe, Canada, US, RoW	Radiofrequency Ablation	Medtronic Cardiac Rhythm and Heart Failure	Persistent Atrial Fibrillation, Atrial Fibrillation	10/24	12/24
Risk, Lindsay
No trials found